Showing all 6 results
Isosorbide Mononitrate Tablets
FreeProduct Composition & Strength
We supply this product as Immediate Release Tablets (20 mg). We also offer Extended Release (ER/SR) variants for once-daily dosing through our contract manufacturing division.
Active Ingredient Strength (Standard) Therapeutic Role Isosorbide Mononitrate BP/USP 20 mg Organic Nitrate / Vasodilator Excipients Q.S. Microcrystalline Cellulose / Lactose Stabilizing Matrix Isosorbide Tablets
FreeProduct Composition & Variants
We supply both Mononitrate and Dinitrate forms in immediate and sustained-release formats.
Variant Type Standard Strengths Primary Clinical Use Isosorbide Mononitrate 10mg, 20mg, 40mg Prophylaxis: Long-term prevention of angina. Isosorbide Dinitrate 5mg, 10mg, 20mg Acute & Chronic: Short and long-term heart failure. Sustained Release (SR) 30mg, 60mg Once-Daily: For improved patient compliance. Nicorandil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Tablet, packed exclusively in highly secure, heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile active ingredient.
Active Ingredient Strength Primary Clinical Function Nicorandil Ph.Eur./BP 5 mg Initiation / Titration Standard: Base therapeutic unit for the mandatory slow-titration protocol required to build patient tolerance and prevent severe “nitrate headaches.” Nicorandil Ph.Eur./BP 10 mg / 20 mg Global Cardiology Standard: High-dose adult maintenance therapy for severe, refractory stable angina pectoris. Excipients Maize Starch / Croscarmellose Sodium / Stearic Acid / Mannitol Low-Moisture Diluent / Superdisintegrant / Lubricant (Engineered specifically without hygroscopic binders to guarantee the tablet remains perfectly dry and structurally intact throughout its shelf life) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic cardiology dispensing regimens).
Nifedipine Tablet
FreeProduct Composition & Structural Formats
We supply Nifedipine in exact, internationally standardized strengths, optimized for immediate-release emergency titration or controlled-release daily maintenance.
Active Ingredient Available Strengths Formulation Mechanism Primary Clinical Target Nifedipine IP / BP / USP 10 mg Immediate or Modified Release Acute Titration / Tocolysis: For rapid blood pressure adjustment or suppression of premature labor. Nifedipine IP / BP / USP 20 mg Sustained / Retard Matrix Daily Maintenance: Continuous 12-to-24-hour plasma concentration for chronic hypertension and angina. Nitroglycerin Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Concentrate for Infusion in glass ampoules or vials. (Must be diluted).
Active Ingredient Strength Total Content Nitroglycerin USP/BP 5 mg/ml 25 mg (in 5 ml Ampoule) Nitroglycerin USP/BP 5 mg/ml 50 mg (in 10 ml Vial) Excipients Propylene Glycol / Ethanol Solubilizers (Volatile) *Pack Sizes: Tray of 5 Ampoules or 10 Vials.
Nitroglycerin Tablet
FreeProduct Composition & Available Strengths
We supply Nitroglycerin Sublingual Tablets in exact, internationally calibrated low-dose strengths to allow for immediate rescue titration during acute ischemic episodes.
Active Ingredient Common Name Compendial Title Available Strengths Primary Clinical Target Nitroglycerin (GTN) Glyceryl Trinitrate IP / BP / USP 0.4 mg Standard Rescue Dose: Preferred international standard for immediate acute angina abortion. Nitroglycerin (GTN) Glyceryl Trinitrate IP / BP / USP 0.5 mg High-Threshold Prophylaxis: Calibrated for heavy coronary spasm management or pre-exertion protection.
